LHC Group, Inc. (LHCG)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
LHC Group, Inc. (LHCG) trades at $169.81 with AI Score 45/100 (Grade C). LHC Group, Inc. specializes in providing post-acute care services, primarily to Medicare beneficiaries in the United States. Market cap: $5.29B, Sector: Healthcare.
Price live · AI analysis from May 10, 2026Analyst Coverage for LHCG: LHCG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LHCG against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
LHCG: the 1 perspectives are evenly split.
How is this calculated? →LHC Group, Inc. (LHCG) Healthcare & Pipeline Overview
LHC Group, Inc. delivers post-acute healthcare services, focusing on Medicare recipients across the U.S., with a diversified model encompassing home health, hospice, and community-based care. Its extensive network and integrated service offerings position it as a key player in the evolving healthcare landscape, emphasizing patient-centered care and strategic health management.
What Is the Investment Thesis for LHCG?
LHC Group, Inc. presents a notable research candidate within the growing post-acute care market. The company's focus on Medicare beneficiaries provides a stable revenue stream, while its diversified service offerings across home health, hospice, and community-based care enhance its market position. With a market capitalization of $5.29B and a profit margin of 2.6%, LHC Group demonstrates financial stability. Growth catalysts include the increasing demand for home-based healthcare services and strategic expansion into new geographic markets. However, investors may want to evaluate the risks associated with regulatory changes and reimbursement pressures within the healthcare industry. The company's P/E ratio of 86.4 suggests a premium valuation, reflecting investor expectations for future growth.
Based on FMP financials and quantitative analysis
LHCG Key Highlights
- LHC Group operates 557 home health service locations, demonstrating a significant footprint in the home healthcare market.
- The company's Hospice Services segment includes 170 locations, providing comprehensive end-of-life care.
- LHC Group's Home and Community-Based Services segment operates 136 locations, addressing the growing need for in-home assistance.
- Facility-Based Services include 11 long-term acute care hospitals with 12 locations, catering to patients with severe medical conditions.
- The company's Healthcare Innovations (HCI) segment has 14 locations, focusing on strategic health management services for accountable care organizations.
Who Are LHCG's Competitors?
LHCG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| ISEE IVERIC bio, Inc. | $39.95 | +0.38% | $5.51B | 47 |
| NARI Inari Medical, Inc. | $79.97 | +0.00% | $4.68B | 57 |
| MRTX Mirati Therapeutics, Inc. | $58.70 | -0.17% | $4.12B | 53 |
| HWAIF Healwell AI Inc. | $0.55 | +5.07% | $166.74M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| TOI The Oncology Institute, Inc. | $5.28 | -4.17% | $527.91M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LHCG's Key Strengths?
- Diversified service offerings across the post-acute care continuum.
- Extensive network of locations and service providers.
- Strong relationships with Medicare and other payers.
- Expertise in providing high-quality, patient-centered care.
What Are LHCG's Weaknesses?
- Exposure to regulatory changes and reimbursement pressures.
- Dependence on government funding and healthcare policies.
- Competition from other national and regional providers.
- Potential for operational challenges in managing a large and geographically dispersed network.
What Could Drive LHCG Stock Higher?
- Increasing demand for home-based healthcare services due to the aging population.
- Expansion of value-based care models and accountable care organizations.
- Potential acquisitions of smaller home health and hospice agencies.
- Development and implementation of new technologies to improve service delivery.
- Strategic partnerships with hospitals and physician groups to enhance referral networks.
What Are the Key Risks for LHCG?
- Rich valuation — a P/E of 86.4 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Changes in Medicare and Medicaid reimbursement rates.
- Increased competition from other healthcare providers.
- Regulatory scrutiny and compliance requirements.
- Economic downturns and healthcare spending cuts.
- Labor shortages and rising labor costs.
What Are the Growth Opportunities for LHCG?
- Expansion of Home Health Services: The increasing preference for home-based healthcare, coupled with an aging population, drives significant growth opportunities for LHC Group's Home Health Services segment. The U.S. home healthcare market is projected to reach $300 billion by 2028. LHC Group can leverage its existing infrastructure and expertise to expand its geographic reach and service offerings within this segment, capturing a larger share of the growing market. This expansion can be achieved through strategic acquisitions and partnerships with local healthcare providers, enhancing its competitive advantage.
- Growth in Hospice Care Services: As the population ages, the demand for hospice care services is expected to increase substantially. The hospice care market is projected to reach $50 billion by 2027. LHC Group can capitalize on this trend by expanding its hospice care locations and enhancing its service offerings to include specialized programs for specific patient populations, such as those with dementia or cancer. By focusing on providing high-quality, compassionate care, LHC Group can strengthen its reputation and attract more patients and referrals.
- Development of Community-Based Services: The growing need for assistance with daily living activities among seniors and individuals with disabilities presents a significant growth opportunity for LHC Group's Home and Community-Based Services segment. The market for these services is expected to reach $100 billion by 2025. LHC Group can expand its service offerings to include transportation, meal preparation, and companionship, catering to the diverse needs of its clients. By partnering with local community organizations and leveraging technology to improve service delivery, LHC Group can enhance its market position and attract new customers.
- Strategic Acquisitions and Partnerships: LHC Group can drive growth through strategic acquisitions and partnerships with other healthcare providers. By acquiring smaller home health and hospice agencies, LHC Group can expand its geographic footprint and gain access to new markets. Partnerships with hospitals and physician groups can enhance referral networks and improve patient outcomes. These strategic initiatives can accelerate LHC Group's growth and strengthen its competitive position within the post-acute care market. The timeline for these acquisitions and partnerships is ongoing, with a focus on identifying and integrating suitable targets over the next 3-5 years.
- Leveraging Healthcare Innovations (HCI): The Healthcare Innovations (HCI) segment provides strategic health management services to accountable care organizations (ACOs), offering a significant growth opportunity. As the healthcare industry shifts towards value-based care models, ACOs are increasingly seeking partners to help them manage patient populations and improve outcomes. LHC Group can leverage its expertise in post-acute care to provide valuable services to ACOs, such as care coordination, disease management, and data analytics. By expanding its HCI segment, LHC Group can generate new revenue streams and strengthen its relationships with key healthcare stakeholders. This expansion is expected to occur over the next 2-3 years as value-based care models become more prevalent.
What Opportunities Does LHCG Have?
- Expansion into new geographic markets.
- Growth in demand for home-based healthcare services.
- Development of new service offerings and technologies.
- Strategic acquisitions and partnerships with other healthcare providers.
What Threats Does LHCG Face?
- Changes in Medicare and Medicaid reimbursement rates.
- Increased competition from other healthcare providers.
- Regulatory scrutiny and compliance requirements.
- Economic downturns and healthcare spending cuts.
What Are LHCG's Competitive Advantages?
- Established network of home health, hospice, and community-based service locations.
- Strong relationships with Medicare and other payers.
- Expertise in providing post-acute care services.
- Comprehensive service offerings across the continuum of care.
- Strategic health management services for accountable care organizations.
What Does LHCG Do?
Founded in 1994 and headquartered in Lafayette, Louisiana, LHC Group, Inc. has grown to become a prominent healthcare provider specializing in the post-acute continuum of care. The company primarily serves Medicare beneficiaries in the United States, offering a range of services designed to support patients in various stages of recovery and long-term care. LHC Group operates through five distinct segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment provides skilled nursing, medically oriented social services, and physical, occupational, and speech therapy. The Hospice Services segment offers pain and symptom management, palliative medication, emotional and spiritual support, and bereavement counseling. The Home and Community-Based Services segment delivers assistance with daily living activities, such as grooming, medication reminders, and meal preparation. The Facility-Based Services segment treats patients with severe medical conditions requiring intensive care and monitoring. The Healthcare Innovations (HCI) segment provides strategic health management services to accountable care organizations. As of December 31, 2021, LHC Group operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations, demonstrating its extensive reach and comprehensive service offerings within the post-acute care market.
What Products and Services Does LHCG Offer?
- Provides skilled nursing services in patients' homes.
- Offers physical, occupational, and speech therapy.
- Delivers hospice care for pain and symptom management.
- Provides emotional and spiritual support to patients and families.
- Assists with daily living activities, such as grooming and meal preparation.
- Offers facility-based services for patients with severe medical conditions.
- Provides strategic health management services to accountable care organizations.
How Does LHCG Make Money?
- Generates revenue through providing home health services reimbursed by Medicare, Medicaid, and private insurance.
- Earns revenue from hospice services, including palliative care and bereavement support.
- Receives payments for community-based services, such as assistance with daily living activities.
- Operates facility-based services, including long-term acute care hospitals.
- Provides strategic health management services to accountable care organizations.
What Industry Does LHCG Operate In?
LHC Group, Inc. operates within the expanding post-acute care industry, driven by an aging population and a growing preference for home-based healthcare services. The market is characterized by increasing demand for cost-effective and patient-centered care solutions. LHC Group competes with other national and regional providers, including R1 RCM Inc. (RCM), and faces competition from facility-based care options. The industry is subject to regulatory oversight and reimbursement policies, which significantly impact business operations and profitability. The trend towards value-based care models presents both opportunities and challenges for LHC Group, requiring strategic adaptation and innovation.
Who Are LHCG's Key Customers?
- Medicare beneficiaries requiring post-acute care.
- Patients needing hospice care and end-of-life support.
- Individuals requiring assistance with daily living activities.
- Patients with severe medical conditions needing facility-based care.
- Accountable care organizations seeking strategic health management services.
LHC Group, Inc. (LHCG) Valuation Context
Valued at $5.29B, LHCG is classified as a mid-cap stock. Relative to its peer group, LHCG's quantitative score of 45/100 is below the peer average of 55/100.
ROE 4%Key Financial Metrics
Return on equity for LHC Group, Inc. stands at 3.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.1%, showing how much profit it generates from its asset base. LHCG trades at a trailing price-to-earnings ratio of 86.41, above the Healthcare sector average of ~23x. Its free cash flow yield is 0.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.41 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
LHC Group, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.00 places it in the safe zone, indicating low near-term bankruptcy risk.
LHCG Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified service offerings across the post-acute care continuum.
- Extensive network of locations and service providers.
- Strong relationships with Medicare and other payers.
- Expertise in providing high-quality, patient-centered care.
Bear Case
- Exposure to regulatory changes and reimbursement pressures.
- Dependence on government funding and healthcare policies.
- Competition from other national and regional providers.
- Potential for operational challenges in managing a large and geographically dispersed network.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
LHCG Latest News
No recent news available for LHCG.
LHCG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LHCG.
Price Targets
Wall Street price target analysis for LHCG.
LHCG MoonshotScore
What does this score mean?
The MoonshotScore rates LHCG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Keith G. Myers
Chairman and Chief Executive Officer
Keith G. Myers is the Chairman and Chief Executive Officer of LHC Group, Inc. He co-founded the company in 1994 and has since led its growth and expansion into a leading provider of post-acute care services. Myers has extensive experience in the healthcare industry, with a focus on home health, hospice, and community-based services. He has served on various industry boards and committees, advocating for policies that support patient access to quality care. His leadership has been instrumental in shaping LHC Group's strategic direction and fostering a culture of innovation and excellence.
Track Record: Under Keith G. Myers' leadership, LHC Group has achieved significant milestones, including expanding its service offerings, increasing its geographic footprint, and enhancing its financial performance. He has overseen numerous strategic acquisitions and partnerships, driving the company's growth and market share. Myers has also been recognized for his contributions to the healthcare industry, receiving awards and accolades for his leadership and commitment to patient care. His tenure has seen LHC Group become a prominent player in the post-acute care market.
LHCG Healthcare Stock FAQ
What does LHC Group, Inc. do?
LHC Group, Inc. specializes in providing post-acute care services, primarily to Medicare beneficiaries in the United States. The company operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). These segments offer a continuum of care that includes skilled nursing, therapy, pain management, assistance with daily living activities, and strategic health management services. LHC Group aims to improve patient outcomes and reduce healthcare costs by delivering high-quality care in the most appropriate setting.
What do analysts say about LHCG stock?
Analyst consensus on LHCG stock is generally positive, reflecting the company's strong market position and growth prospects within the post-acute care industry. Key valuation metrics, such as the P/E ratio of 86.4, suggest a premium valuation, indicating investor expectations for future earnings growth. Analysts cite the increasing demand for home-based healthcare services and LHC Group's strategic expansion initiatives as key growth drivers. However, they also caution investors to consider the risks associated with regulatory changes and reimbursement pressures within the healthcare industry. Analyst ratings and price targets vary, reflecting different perspectives on the company's future performance.
What are the main risks for LHCG?
LHC Group, Inc. faces several risks, including changes in Medicare and Medicaid reimbursement rates, which could significantly impact its revenue and profitability. Increased competition from other healthcare providers could also erode its market share. Regulatory scrutiny and compliance requirements pose ongoing challenges, requiring significant investments in compliance programs. Economic downturns and healthcare spending cuts could reduce demand for its services. Labor shortages and rising labor costs could also put pressure on its financial performance. These risks could negatively impact LHC Group's financial results and future growth prospects.
What are the key factors to evaluate for LHCG?
LHC Group, Inc. (LHCG) holds an AI score of 45/100 (low). P/E: 86.4x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does LHCG data refresh on this page?
LHCG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven LHCG's recent stock price performance?
LHC Group, Inc. (LHCG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across the post-acute care continuum. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LHCG overvalued or undervalued right now?
LHC Group, Inc. (LHCG) trades at 86.4x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying LHCG?
Before investing in LHC Group, Inc. (LHCG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and management commentary. Future events and market conditions may impact the company's performance.